Single Annual EMA Fee Proposal Holds Most Promise For Pharma
Annual Fee Concept Can Simplify Many Of The Current Complexities
Executive Summary
Europe’s research-based industry association picks its preferred way forward for simplifying the European Medicines Agency’s fee system.
You may also be interested in...
Loud And Clear: EMA Gets Message On Advancing Reg Science
The European Medicines Agency has identified key areas where stakeholders want to see it deliver a real change over the next five years.
Keep It Simple: EU Consults On Future Design Of EMA’s Fee System
Following a report that identified several shortcomings of the European Medicines Agency fee system, the European Commission has suggested various options to make it sustainable and future-proof.
Roche’s Eye Drug Scores First UK Approval Under Access Consortium
The UK MHRA has approved its first drug under an international work-sharing initiative that also includes regulators from Australia, Canada, Singapore and Switzerland.